Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer demonstrates the efficacy of IL-8 inhibitors in overcoming resistance to chemotherapy in gastric cancer [41], which underscores the potential utility of similar strategies in MPE. Here, CXCL8 is linked to gastric cancer.